Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NETWORK 34OTHER 31INDUSTRY 12NIH 6OTHER_GOV 2UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Triple Negative Breast Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 6Radiotherapy 3Epirubicin 3Radiation Dose Hypofractionation 2Radiation 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Capecitabine 2pegylated granulocyte colony-stimulating factor 1nabiximols 1aumolertinib 1Zoledronic Acid 1Vinorelbine 1Temozolomide 1TP protocol 1Standard of Care 1S 1 (combination) 1Radiotherapy, Intensity-Modulated 1Platinum 1Pemetrexed 1Neoadjuvant Therapy 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Decitabine 1Chemotherapy, Adjuvant 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × UNKNOWN × Granulocyte Colony-Stimulating Factor × Clear all
NCT01378533 2011-12-28

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

ChineseAMS

Phase 3 Unknown
100 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡